Zhejiang Hisun Pharmaceutical Co (SHSE:600267) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600267 Zhejiang Hisun Pharmaceutical Co Ltd SHSE:600267
58 GF Score
Price ¥11.72
GF Value ¥8.85
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Zhejiang Hisun Pharmaceutical Co Float Percentage Of Total Shares Outstanding?

Zhejiang Hisun Pharmaceutical Co SHSE:600267 -1.18% 58 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 28, 2026. GuruFocus rates SHSE:600267 with a GF Score™ of 58/100 and a GF Value™ of ¥8.85 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Zhejiang Hisun Pharmaceutical Co's float shares is 0.00 Mil. Zhejiang Hisun Pharmaceutical Co's total shares outstanding is 1,180.27 Mil. Zhejiang Hisun Pharmaceutical Co's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Zhejiang Hisun Pharmaceutical Co's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Zhejiang Hisun Pharmaceutical Co's Institutional Ownership is 4.93%.

SHSE:600267
58GF Score
Zhejiang Hisun Pharmaceutical Co Ltd SHSE:600267
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Hisun Pharmaceutical Co Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Zhejiang Hisun Pharmaceutical Co's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/1,180.27
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Zhejiang Hisun Pharmaceutical Co (SHSE:600267) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 28, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Zhejiang Hisun Pharmaceutical Co and its competitors.
Is Zhejiang Hisun Pharmaceutical Co's Float Percentage Of Total Shares Outstanding too high?
Zhejiang Hisun Pharmaceutical Co's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Zhejiang Hisun Pharmaceutical Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Hisun Pharmaceutical Co's Float Percentage Of Total Shares Outstanding compare to ZTS?
Zhejiang Hisun Pharmaceutical Co's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Zhejiang Hisun Pharmaceutical Co and its competitors. Zhejiang Hisun Pharmaceutical Co's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Hisun Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Hisun Pharmaceutical Co (SHSE:600267) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.85, compared to a current price of ¥11.72 — trading 32.4% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Zhejiang Hisun Pharmaceutical Co's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Zhejiang Hisun Pharmaceutical Co (SHSE:600267), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Hisun Pharmaceutical Co (SHSE:600267) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Hisun Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥11.72 is trading 32.4% above its estimated GF Value™ of ¥8.85. GuruFocus considers Zhejiang Hisun Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:600267:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: ¥8.85 vs. price of ¥11.72 (32.4% above fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600267 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Hisun Pharmaceutical Co Business Description

Address No. 46 Waisha Road, Jiaojiang District, Zhejiang Province, Taizhou, CHN, 318000
Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.
58GF Score

Get the complete analysis for SHSE:600267

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.72
Price
¥8.85
GF Value